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1 Introduction
During the synthesis of pharmaceuticals, significant con-
tamination with some impurities may occur. They can be 
either intentionally added to the process (e.g., residual 
catalyst or reactants) or introduced from the equipment 
or the drug packages.1 Either way, they need to be con-
trolled. Many chemical reactions are accelerated by using 
metal-based catalysts. In addition, most of the equipment 
is made of metal materials (reaction vessels, mixing tanks, 
filters, etc.). Therefore, it is highly expected that traces of 
metals will appear in pharmaceutical products.2,3 Metals 
present in the active pharmaceutical ingredient (API) are 
of great concern due to the possible toxicity of the metals 
present in the product, which could put human health at 
high risk.4
Elemental impurities control is a segment of pharmaceuti-
cal quality control, which ensures that elemental impurities 
stay within the permitted daily exposure (PDE) limits for 
specific pharmaceutical product. The European Medicines 
Agency (EMA) has issued a Guideline (Q3D) by the Inter-
national Council for Harmonisation of Technical Require-
ments for Registration of Pharmaceuticals for Human Use 
(ICH), in which the steps to control the elemental impuri-
ties in the pharmaceuticals are given.5
Before guideline ICH Q3D, total metal content in API was 
analysed following British and American Pharmacopeias.6,7 
According to them, total metal content in API is measured 
through the reactions between the metal in the sample and 
thioacetamide reagent. It precipitates metals in the form of 
coloured sulfides. The colour is compared with a parallel 
treated standard solution of lead. The total heavy metal 
content is expressed relative to the standard lead solution. 
Although still in use, this method is non-specific and insen-
sitive, time-consuming, and very often has low usability. 
Non-specificity means that this method provides no infor-
mation about which heavy metal gives a positive result, 
which is a great disadvantage of the method.8
On the other hand, ICH Q3D Guideline separates 24 el-
emental impurities in three classes, based on their toxicity 
(expressed as PDE) and probability of their occurrence in 
the product. Table 1 shows the PDE limits of elemental im-
purities for oral consumption for the purpose of evaluation 
of elemental impurities contamination, with the maximum 
dosage of 10 g day−1.
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Abstract
Fosamprenavir calcium is an active pharmaceutical ingredient (API) in which trace elements must be monitored by ICH Q3D 
Guideline. It delivers appropriate method to ensure the quality of the product and its safe use. Elemental impurities in API are 
separated in three classes based on their toxicity and probability of their occurrence in the product. ICP-MS has proven to be 
a suitable technique with the appropriate sample preparation method. Due to the presence of oxidising agents in the sample 
preparation, determination of osmium is problematic. In the presence of oxidising nitric acid, a highly volatile and toxic os-
mium tetraoxide is formed. Due to its high volatility, the recovery of osmium has reached the value of 287 %, which exceeds 
recovery limit (70–150 %). However, osmium can be stabilised by complexation with thiourea in the hydrochloric acid solution 
(recovery = 87 %). In that way, the loss of osmium is reduced and good results are achieved in terms of usability, accuracy, 
and precision. 
A method with addition of thiourea has been successfully validated through main validation parameters: linearity, quantitation 
limit, selectivity, accuracy, precision (which included repeatability and intralaboratory reproducibility), and robustness. Each 
of these validation parameters met the acceptance criteria, and therefore it was concluded that the method is suitable for the 
determination of trace elements in fosamprenavir calcium by ICP-MS.
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Table 1 – Oral consumption limits for daily (10 g) pharmaceuti-
cal intake issued by ICH Q3D Guidelines
Tablica 1 – Dopuštene koncentracije unosa metala za dnevni 
unos lijekova (10 g) prema smjernicama ICH Q3D 
Element Class Oral consumption limits ⁄ µg g−1







Au, Pd, Ir, Os,  
Rh, Ru, Pt 2B 10








The ICH Q3D Guideline follows the suggestions of USP 
h233i very closely.6 It applies traditional sample prepara-
tion (such as microwave digestion) with inductively cou-
pled plasma (ICP). Heavy metals in pharmaceuticals are 
nowadays most commonly analysed by ICP-MS technique. 
The advantages of this technique are very simple sample 
preparation, small quantities of the samples needed for the 
analysis, good sensitivity, and possibility to screen a wide 
spectrum of elements in a relatively short time.9,10,11,12 For 
many elements, these approaches deliver excellent results 
in terms of precision and accuracy.13 On the other hand, 
oxidising agents in sample preparation may cause a prob-
lem in determination of osmium traces. Osmium can occur 
in pharmaceuticals as a residual of catalyst or can be found 
in catalysts based on some other metals.14 In certified refer-
ence standards (CRS), osmium is found dissolved in diluted 
HCl solution as salt ((NH4)2OsCl6).When exposed to the 
nitric acid at elevated temperatures, osmium forms high-
ly volatile and extremely toxic osmium tetraoxide (OsO4). 
Additionally, due to its volatility, a sample loss during the 
sample preparation is possible. If the preparation is fast and 
precise, the results of osmium analysis can give falsely ele-
vated responses. It evaporates even more in the nebulizer, 
after which it reaches the plasma, and eventually comes to 
the detector.15
Thus, for the collective determination of all elements re-
quired by ICH Q3D Guideline, including osmium, a 
simple and effective method of stabilisation for osmium 
is required.13 A literature search revealed that osmium 
tetraoxide could be complexed with thiourea prepared in 
diluted HCl solution, and thus stabilized.16
In this study, the samples of API fosamprenavir calcium 
were prepared by several microwave digestion methods 
for the determination of the trace elements. The most suit-
able microwave digestion method was applied, and the 
ICP-MS method validated. 
2 Experimental
2.1 Chemicals
Fosamprenavir calcium as tested API was obtained by Pliva 
Croatia d. o. o., and used in the form of powder. ICP-MS 
method validation was performed with the Certificated 
Reference Standards (CRS, Inorganic Ventures, USA). The 
CRS with their nominal concentrations are presented in 
Table 2.
Table 2 – Certificated Reference Standards (CRS)
Tablica 2 – Certificirani standardi
Name γ ⁄ ppm Name γ ⁄ ppm Name γ ⁄ ppm Name γ ⁄ ppm
Ag 1000 Cu 10000 Pd 1000 Tl 10 
As 10 Hg 1000 Pt 1000 V 1000 
Au 1000 Ir 1000 Rh 1000 Sc 1000 
Ba 10000 Li 1000 Ru 1000 Ge 1000 
Cd 10 Mo 10000 Sb 1000 Dy 1000 
Co 1000 Ni 1000 Se 1000 In 1000 
Cr 10000 Pb 10 Sn 10000 Os 1000 
As dissolving agents, following chemicals were used: nitric 
acid (69.0–70.0 %, trace element analysis grade, J. T. Bak-
er, USA), perchloric acid (69–72 %, trace element analysis 
grade, J. T. Baker, USA), hydrochloric acid (36.5–38.0 %, 
trace element analysis grade, J. T. Baker, USA), and hydro-
gen peroxide (30 %, Merck, USA). 
Thiourea (≥99.999 %, Sigma-Aldrich, USA) was used in 
sample preparation procedure for osmium determination. 
During all of the experiments, ultra-pure water was used 
(18.2 MΩ cm, Mili-Q Advantage, Merck, USA).
2.2 ICP-MS system 
For trace metal analysis, Agilent Technologies ICP-MS 
7700x and 7900 were used (Agilent Technologies, Santa 
Clara, CA, USA). Since both devices are equivalent, their 
characteristics are described jointly. The sample flow of 
quartz concentric pneumatic sprayer was ~0.2 ml min−1. 
Quartz low-volume Scott-type chamber with double pas-
sage was used for liquid separation. For sample intake, in-
ternal standard intake, and disposal drainage from liquid 
separation chamber was performed by peristaltic pump. 
Radio-frequent generator was characterised with the 
27 MHz variable frequency impedance, and the working 
power range of 500–1600 W. Plasma torch was made of 
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2.5 mm quartz glass. A pair of cones were made of cop-
per with nickel tip: first cone for sampling with 1 mm gap, 
and second cone as the skimmer cone with 0.45 mm gap. 
Argon was used as carrier gas with flow rate of 1.0 l min−1, 
while helium was used as collision gas with flow rate of 
5.0 ml min−1. Octopole 4th generation reaction system pro-
vided fast gas exchange and effective interference elimina-
tion with kinetic energy-based discrimination in collision 
helium-mode for 51V, 52Cr, 59Co, 60Ni, 63Cu, 75As, and 78Se. 
Mass spectrometry system had hyperbolic quadrupole 
analyser with high frequency working mode (3 MHz), and 
the orthogonal detector system with high linear dynamic 
range of 11 orders of magnitude. 
In ICP-MS techniques, internal standards (ISTD) can be 
used for tracking system stability and possible analyte loss. 
Good candidates for internal standards are usually ele-
ments not normally expected in the matrix and not ana-
lytes of interest, but which have good response and stabil-
ity. In this research, ISTD was prepared in 25 mg l−1 mass 
concentration. It was assumed that the same effect would 
equally change the response of analyte of interest, as well 
as the internal standard response. Therefore, used ICP-MS 
software automatically corrected concentration of each 
analyte with regard to added internal standard, the result 
being the relative ratio of the analyte signal and the internal 
standard signal. As internal standards, Sc, Ge, Dy, and In 
were used: 7Li/45Sc, 51V/45Sc, 52Cr/45Sc, 59Co/45Sc, 60Ni/45Sc, 
63Cu/45Sc, 75As/72Ge, 78Se/72Ge, 95Mo/115In, 101Ru/115In, 
103Rh/115In, 105Pd/115In, 107Ag/115In, 111Cd/115In, 118Sn/115In, 
121Sb/115In, 138Ba/115In, 189Os/163Dy, 193Ir/163Dy, 195Pt/163Dy, 
197Au/163Dy, 202Hg/163Dy, 205Tl/163Dy, 208Pb/163Dy.17,18
For data analysis, MassHunter computer software was used 
(Agilent Technologies, Santa Clara, CA, USA).
2.3 Preparation of standard solutions
Standard solutions were used for ICP-MS calibration and 
linearity testing, as well for method performance testing as 
standard addition (spiking of samples with standard solu-
tions). Working standard solutions were made to have ex-
actly 0, 10, 30, 50, 100, 150, and 200 % concentration 
of each element, according to ICH Q3D requirement for 
oral consumption (Table 1). Diluent solution 1 contained 
2.5 % v/v HCl, and it was used for sample preparation of 
fosamprenavir calcium in which Ag, As, Au, Ba, Cd, Co, 
Cr, Cu, Hg, Ir, Li, Mo, Ni, Pb, Pd, Pt, Rh, Ru, Sb, Se, Sn, Tl, 
and V would be determined. Diluent solution 2 contained 
0.01 M thiourea in 2.5 % v/v HCl. Thiourea was added 
to complex volatile and toxic osmium tetraoxide, which is 
the product of osmium and nitric acid reaction. Therefore, 
diluent solution 2 was used to determine the trace osmium 
in the samples.
2.4 Sample preparation
Fosamprenavir calcium has very low solubility in water, 
which improves with the acidification and has its peak at 
pH 3–4. Regardless, the sample must be completely dis-
solved in order to be analysed on ICP-MS systems. There-
fore, different combinations of various acids and micro-
wave digestion under increased pressure and temperature 
conditions were tested using microwave chamber (Ultra-
Wave, Milestone, Italy).
Fosamprenavir calcium powder was homogenised, 
weighed 50 mg (± 10 %) (analytical balance Mettler To-
ledo AX205 DeltaRange, OH, USA), and put into quartz 
cuvettes. Mixture of acids (Table 3) and 100 µl of ISTD 
were added to the sample in the cuvettes. Cuvettes were 
closed, shaken, and placed for microwave digestion ac-
cording to the program described in Table 3. After micro-
wave digestion, samples were quantitatively transferred 
to 50-ml polypropylene volumetric flasks, and filled with 
dilution solution 1 to the mark. Results showed that, in 
most combinations of acids, the sample remained undis-
solved under microwave digestion. Combination of nitric 
acid and perchloric acid dissolved the sample. For further 
analysis and method validation, 5 ml of HNO3 and 250 µl 
of HClO4 was used.
Table 3 – Microwave digestion program and combination of ac-
ids
Tablica 3 – Program mikrovalne digestije i kombinacije kiselina
# t ⁄ min P ⁄ W T1 ⁄ °C T2 ⁄ °C p ⁄ bar
1 25 1500 210 70 130
2 20 1500 210 70 130
Combination of acids for micro-
wave digestion Sample state after digestion
5.00 ml HNO3 Undissolved
5.00 ml HCl Undissolved
4.00 ml HNO3 + 1.00 ml HCl Undissolved
4.00 ml HNO3 + 0.25 ml HClO4 
+ 1.00 ml HCl Undissolved
4.00 ml HNO3 + 0.25 ml HClO4 Undissolved
4.00 ml HNO3 + 0.50 ml HClO4 Dissolved
5.00 ml HNO3 + 0.25 ml HClO4 Dissolved
The blank sample was made in the same manner, contain-
ing the mixture of acids (5 ml of HNO3, 250 µl of HClO4) 
and 100 µl of ISTD, but without the addition of fosam-
prenavir calcium. After microwave digestion, it was trans-
ferred to 50-ml polypropylene volumetric flasks, and filled 
with dilution solution 1 to the mark.
3 Results and discussion
3.1 ICP-MS method validation
Analyses performed in this work included rigorous system 
suitability testing. Critical performance characteristics were 
measured and verified according to appropriate accept-
ance criteria for every analyte (Table 4).
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Table 4 – Validation acceptance criteria
Tablica 4 – Prihvatljivi kriteriji validacije
Validation parameter Acceptance criteria
Specificity
Recovery 70 – 150 %
Linearity
Correlation coefficient ≥ 0.9900
Quantitation limit
Value 10 % PDE
RSD (10 % PDE) ≤ 20 %
Accuracy
Recovery level 1 (30 % PDE)
70 – 150 %Recovery level 2 (100 % PDE)
Recovery level 3 (150 % PDE)
Precision
Repeatability ≤ 20 %
Reproducibility ≤ 20 %
Total ≤ 25 %
Robustness
Error ≤ 10 %
Specificity is the ability to unambiguously determine the 
analyte in the presence of components that can be expect-
ed in a prepared sample. Usually, this includes impurities, 
degradation products, matrix ingredients, etc. Specificity 
is, therefore, the parameter that indicates how much a 
component in the complex sample matrix interferes with 
analyte determination. It is expressed as recovery of the 
lowest investigated concentration, in this case 10 % PDE. 
Osmium is found in the dissolved form in the used CRS as 
ammonium salt of complex: [OsCl6]2−. When exposed to 
oxidative conditions of nitric acid, especially at elevated 
temperatures, osmium forms a highly volatile and extremely 
toxic osmium tetraoxide (OsO4). The main issue with OsO4 
is the loss of analyte during sample preparation due to its 
volatility and consequently its falsely elevated response. Vol-
atility causes an increased extent in the nebulizer, resulting 
in an elevated concentration when reaching the detector.13
In literature, it was found that OsO4 can be complexed 
with thiourea prepared in diluted HCl solution. Therefore, 
preliminary tests were performed using a dilution solution 
containing 0.01 mol l−1 thiourea in 2.5 % v/v HCl (dilution 
solution 2). Results had significantly improved compared 
to those obtained by analysis with dilution solution con-
taining only 2.5 % v/v HCl (dilution solution 1). 
Regression analysis data for Ag, As, Au, Ba, Cd, Co, Cr, Cu, 
Hg, Ir, Li, Mo, Ni, Os, Pb, Pd, Pt, Rh, Ru, Sb, Se, Sn, Tl, and 
V in fosamprenavir calcium with the addition of thiourea 
analysed by the ICP-MS technique are given in Table 5. 
The developed method gives linear results for all the ex-
amined elements and satisfies the acceptance criterion for 
linearity, which demands a correlation factor greater than 
or equal to 0.9900. Obtained results showed that silver 
had the lowest correlation factor of 0.9989. Limit of detec-
tion was calculated from RSD of the lowest concentration 
investigated.
Table  5 – Regresion analysis data for trace elements in fosam-
prenavir calcium with the addition of thiourea ana-
lysed by the ICP-MS
Tablica 5 – Podatci regresijske analize ICP-MS određivanja eleme-
nata u tragovima u fosamprenavir kalciju uz dodatak 
tiouree
Element R LOD ⁄ ng ml−1 Slope Intercept
Li 0.9995 0.0032 0.0047 1.5739 ∙ 10−4
V 0.9999 0.0635 0.0741 0.0547
Cr 1.0000 0.0350 0.1063 0.0227
Co 0.9999 0.0006 0.2064 1.6291 ∙ 10−4
Ni 0.9999 0.0125 0.0594 0.0059
Cu 0.9998 0.0406 0.1602 0.1676
As 0.9994 0.0141 0.0122 4.3694 ∙ 10−4
Se 0.9998 0.2192 4.7553 ∙ 10−4 1.8680 ∙ 10−4
Mo 0.9993 0.0100 0.0028 1.6241 ∙ 10−4
Ru 0.9997 0.0023 0.0033 7.4044 ∙ 10−6
Rh 0.9992 0.0004 0.0173 8.9351 ∙ 10−6
Pd 0.9997 0.0042 0.0036 1.2636 ∙ 10−4
Ag 0.9989 0.0031 0.0069 2.2655 ∙ 10−5
Cd 0.9997 0.0003 0.0025 3.6556 ∙ 10−6
Sn 0.9996 0.0388 0.0043 0.0021
Sb 0.9996 0.0017 0.0058 8.9905 ∙ 10−5
Ba 0.9998 0.0013 0.0143 1.2134 ∙ 10−4
Os 0.9999 0.0173 0.0113 6.0422 ∙ 10−4
Ir 0.9999 0.0012 0.0338 2.5141 ∙ 10−4
Pt 0.9999 0.0031 0.0120 2.0969 ∙ 10−5
Au 0.9999 0.0042 0.0174 1.6016 ∙ 10−4
Hg 0.9999 0.0051 0.0055 1.6007 ∙ 10−4
Tl 0.9997 0.0017 0.0422 4.4806 ∙ 10−4
Pb 0.9998 0.0018 0.0609 2.7836 ∙ 10−4
3.2 Quantitation limit 
Quantitation limit was determined at 10 % PDE (Provided 
by ICH Q3D, Table 1). The obtained response values were 
converted into mass fractions of each individual contami-
nant in the sample, and in relation to the actually added 
quantities of elements, the individual recoveries (%) were 
determined. RSD (%) of six measurements with and with-
out addition of thiourea were determined (Fig. 1). As results 
showed, the ICP-MS method in the presence of thiourea 
for analysis of trace elements in fosamprenavir calcium 
yielded good results with values of RSD (10 % PDE) lower 
than 10 %. Analyses of Os and Hg, which showed values of 
RSD greater than 10 %, had significantly improved with the 
addition of thiourea. In case of Pb, there was an opposite 
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effect but within the criteria limits. The quantitation lim-
its for each tested element, determined by used method, 
meet the acceptability criteria, which stipulate efficiency in 
the range of 70 to 150 % and RSD of measurements lower 
than 10 %. The lowest average efficiency of the method 
was obtained for thallium and its value was 83 %, while the 
highest value of 110 % was obtained for cadmium.
3.3 Accuracy
The accuracy test was performed on 12 samples; the first 
three were prepared without standard addition, and the 
next three series with three samples, contained standard 
addition at 30, 100, and 150 % of limit values prescribed 
by the ICH Q3D guidelines for oral products. The meas-
ured concentrations were converted to mass fractions for 
each prepared sample, and compared to the value of the 
corresponding standard additive. The results are presented 
as recovery (%) for each individual element, as shown in 
Fig. 3. The accuracy for each element, determined by this 
method, at each tested level, satisfied the acceptance cri-
teria, which require recovery in the range of 70 to 150 % 
in relation to the value of the standard addition. The lowest 
efficiency for the tested accuracy of 86 % was obtained for 
vanadium at the standard addition of 30 % of the maxi-
mum allowable amount, while the highest value of 130 % 
was obtained for molybdenum also at the standard addi-
tion of 30 % of the maximum allowable amount. 
Recovery of osmium without addition of thiourea exceed-
ed recovery range (287 %). This could be attributed to the 
high volatility of osmium in the presence of oxidising nitric 
acid. Addition of thiourea in hydrochloric acid to osmium 
achieved good results with 87 % recovery. 
By satisfying the acceptance criteria results of the accuracy 
test, the specificity of the ICP-MS method for determining 
all investigated elements in fosamprenavir calcium were 
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Fig. 1 – Recovery (%) of each trace element on 10 % PDE; with and without addition of 
thiourea
Slika 1 – Relativna standardna devijacija (%) za sve elemente u tragovima na 10 % PDE, s 
dodatkom i bez dodatka tiouree
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Fig. 2 – RSD (%) of each trace element on 10 % PDE; with and without addition of thiourea
Slika 2 – Analitički povrat (%) za sve elemente u tragovima na 10 % PDE, s dodatkom i bez 
dodatka tiouree
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3.4 Precision
The precision of the ICP-MS method was evaluated on two 
levels, as repeatability and intralaboratory reproducibility. 
The results are presented as relative standard deviations of 
repeated measurements on the same instrument (repeat-
ability), and on another instrument the day after with an-
other analyst. Repeatability was tested with six equally pre-
pared samples and the standard addition of each individual 
test element with 100 % of the limit amount prescribed by 
the ICH Q3D guidelines. The results are presented as a rel-
atively standard deviation of the obtained values, as shown 
in Table 6. Developed ICP-MS method for determination 
of trace elements in fosamprenavir calcium gave good re-
sults and satisfied the acceptance criteria, which require 
the RSD between the measurements less than or equal to 
20 %. The highest RSD between the measurements for the 
performed repeatability test was obtained for Se with the 
value of 9 %. 
Intralaboratory reproducibility was tested based on the 
samples prepared for the repeatability testing. These sam-
ples were re-analysed in the same manner the next day by 
the equivalent instrument. The results are presented as a 
RSD (%) of the obtained values, as shown in Table 6. The 
intralaboratory precision for each tested element deter-
mined by the developed method satisfied the acceptance 
criteria according to Table 4 (RSD ≤ 20 %). The highest 
RSD between measurements for the performed intralab-
oratory precision test was achieved for lithium with RSD 
of 11 %. The total precision results (total RSD (%)) are ex-
pressed as the sum of RSD (%) of method repeatability and 
method reproducibility (Table 6). The results meet the ac-
ceptability criteria where the total RSD must be less than 
or equal to 25 %. The lowest precisions were obtained for 
lithium, nickel, and selenium, with values of 14, 13, and 
14 %, respectively.
3.5 Robustness
Developed ICP-MS method was subjected to a robustness 
test. Slight changes in microwave digestion conditions in 
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Fig. 3 – Accuracy of ICP-MS method expressed by recovery
Slika 3 – Preciznost ICP-MS metode izražene preko analitičkog povrata
Table  6 – Preciznost izražena kao ponovljivost i unutarlaborato-
rijska obnovljivost










Total RSD ⁄ %
Li 3 11 14
V 1 1 2
Cr 1 1 2
Co 5 1 6
Ni 5 8 13
Cu 1 1 2
As 1 2 3
Se 9 5 14
Mo 1 2 3
Ru 1 1 2
Rh 1 1 2
Pd 1 1 2
Ag 1 2 3
Cd 1 3 4
Sn 1 1 2
Sb 1 1 2
Ba 1 1 2
Os 3 3 6
Ir 0 1 1
Pt 2 1 3
Au 1 2 3
Hg 2 1 3
Tl 0 1 1
Pb 1 2 3
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terms of temperature and concentration of acid added to 
samples were applied. After digestion, all samples were 
dissolved and analysed by ICP-MS according to the instru-
mental conditions prescribed for the developed method. 
The results presented in the form of the relative difference 
between the reference measurement (using the results ob-
tained by repeatability measurement) and the measure-
ments performed in robustness test are shown in Table 7. 
Column 1 describes the relative difference between the 
reference measurement results and the results obtained 
from the analysis of samples prepared with decreased mi-
crowave digestion temperature by 10 °C (200 °C), column 
2 shows results after increasing microwave digestion tem-
perature by 10 °C (220 °C). Columns 3 and 4 represent 
results obtained when concentrations of the nitric acid and 
the perchloric acid were reduced. Results obtained by ro-
bustness test met the acceptability criteria, which require 
relative differences in the results between the measure-
ment of samples with modified preparation and the meas-
urement of samples prepared under prescribed conditions 
to be less than or equal to 10 %. Each condition change 
that was tested for every examined element fulfilled the 
criteria and confirmed the resistance and robustness of the 
method used for the trace elements in fosamprenavir cal-
cium analysis. In the case of osmium, microwave digestion 
at elevated temperature proved to be a critical parameter 
in the sample preparation process. This is understandable 
and expected, given the volatility of the osmium tetraoxide 
formed in contact with the oxidising nitric acid. Therefore, 
it is certainly important to pay attention to the stability of 
the microwave reactor. On the other hand, there was no 
significant effect of diluted nitric and perchloric acids on 
the obtained results. Generally, better yields were obtained 
by conducting the microwave digestion at lower tempera-
tures and using the quartz cuvettes of smaller volume.
4 Conclusions
Impurities in pharmaceutical products in the form of trace 
elements must be monitored by appropriate methods to 
ensure the quality of the product and its safe use. ICP-MS 
has proven to be a suitable technique due to its character-
istics of fast and multi-element analysis, and low detection 
limits necessary for the determination of trace elements. 
With good instrumental methods, sample preparation is 
the other factor for trace elements in API method develop-
ment. Therefore, two sample preparation methods were 
developed for the determination of elemental impurities 
in fosamprenavir calcium. Based on the conducted exper-
iments, the following can be concluded: 
1. Sample preparation is a critical parameter in the analysis 
of elemental contaminants by ICP-MS technique. Careful 
preparation and usage of equipment, chemicals, reagents, 
and certified reference standards of high quality and purity 
is necessary to prevent the possible introduction of con-
taminants into the sample. It is also necessary to take into 
account all the procedures (weighing, reagent addition, 
microwave digestion, replenishment) that could lead to a 
loss of analyte in any way. It is necessary to strictly adhere 
to the prescribed procedures for each step in order to en-
sure quality and reliable results. 
2. The interference present must be kept at a minimum 
using collision gas and the selection of suitable analyte 
isotopes and, where appropriate, by the introduction of 
additional procedures to eliminate interference present in 
the sample matrix. 
3. Osmium, in the presence of oxidising nitric acid gives a 
highly volatile and toxic osmium tetraoxide, which can be 
stabilized by complexation with thiourea in hydrochloric 
acid solution. In that way, the loss of osmium is reduced, 
and significantly better results are achieved in terms of us-
ability, accuracy and precision.
4. The validation procedure confirmed that the developed 
ICP-MS method obtained specific, accurate and precise 
results within the method of the defined working range 
for each determined element. In case of element osmium, 
Table  7 – Robustness of the ICP-MS method for analysis of trace 
elements
Tablica 7 – Robustnost ICP-MS metode za analizu metala u tra-
govima
 1 2 3 4







Li 8.32 % 1.32 % 1.54 % 0.78 %
V 1.22 % 0.87 % 1.53 % 0.78 %
Cr 0.97 % 0.50 % 1.92 % 0.86 %
Co 2.00  % 5.15 % 5.07 % 6.71 %
Ni 5.36 % 8.38 % 3.46 % 2.45 %
Cu 2.99 % 1.17 % 1.60 % 0.31 %
As 2.19 % 1.22 % 0.83 % 0.76 %
Se 2.02 % 4.20 % 0.06 % 1.46 %
Mo 0.51 % 2.05 % 0.07 % 0.90 %
Ru 1.49 % 1.06 % 1.73 % 1.79 %
Rh 2.09 % 1.13 % 0.80 % 0.69 %
Pd 2.25 % 0.93 % 1.17 % 1.81 %
Ag 4.98 % 4.94 % 3.32 % 3.02 %
Cd 4.02 % 6.86 % 7.94 % 8.50 %
Sn 0.76 % 1.10 % 1.25 % 1.82%
Sb 2.78 % 0.35 % 5.28 % 1.62  %
Ba 0.31 % 0.97 % 2.15 % 2.76 %
Os 5.26 % 9.48 % 3.60 % 0.43 %
Ir 3.02 % 2.93 % 2.99 % 2.61 %
Pt 0.54 % 1.22 % 0.74 % 1.20 %
Au 1.15 % 4.48 % 0.38 % 1.57 %
Hg 1.02 % 1.92 % 0.04 % 1.47 %
Tl 1.49 % 4.47 % 1.27 % 0.86 %
Pb 0.10 % 0.24 % 1.25 % 1.07 %
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sample preparation was found to be critical factor. Addi-
tion of thiourea resolved the issue of volatile and poison-
ous osmium tetraoxide. With thiourea added to the sam-
ple, the whole method was successfully validated through 
main validation parameters: linearity, quantitation limit, 
selectivity, accuracy, precision (which included repeata-
bility and intralaboratory reproducibility), and robustness. 
Each of these validation parameters met the acceptance 
criteria. Thus, it was concluded that the method is suitable 
for the determination of trace elements in fosamprenavir 
calcium by ICP-MS.
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SAŽETAK
Validacija ICP-MS metode za određivanje metala u tragovima prema 
ICH Q3D smjernicama u fosamprenavir kalciju
Irena Radić,a Mislav Runje,a Matija Cvetnić,b* Maja Halužan,c Mario-Livio Jeličić,d  
Martina Miloloža,b Dajana Kučić Grgić,b Viktorija Prevarić,b Šime Ukić b i Tomislav Bolanča b,e
Fosamprenavir kalcij je aktivna farmaceutska tvar (API) u kojoj se elementi u tragovima moraju 
nadzirati prema ICH Q3D smjernicama. ICH Q3D smjernice donose odgovarajuću metodu za 
osiguravanje kvalitete proizvoda i njegove sigurne uporabe. Elementarne nečistoće u API-ju raz-
dvajaju se u tri razreda na temelju njihove toksičnosti i vjerojatnosti da se pojave u proizvodu. 
ICP-MS se pokazala kao prikladna tehnika ako se primijeni odgovarajuća metoda pripreme uzora-
ka. Zbog prisutnosti oksidirajućih sredstava u pripremi uzoraka problem se javlja kod određivanja 
osmija. Osmij u prisutnosti oksidirajuće dušične kiseline daje visoko hlapljiv i toksičan osmij te-
traoksid. Zbog visoke hlapljivosti, iskorištenje osmija iznosi 287 %, što premašuje zadanu granicu 
iskorištenja (70 – 150 %). Međutim, osmij se može stabilizirati kompleksiranjem s tioureom u 
otopini klorovodične kiseline (povrat od 87 %). Na taj se način smanjuje njegov gubitak, a postižu 
se dobri rezultati u pogledu točnosti, preciznosti i robusnosti metode.
Ključne riječi 
Mikrovalna digestija, ICP-MS, aktivna farmaceutska tvar, fosamprenavir kalcij, osmij
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